Long-Term Survival of Women with Locally Advanced Breast Cancer with ≥10 Involved Lymph Nodes at Diagnosis |
Zeichner, Simon Blechman
(Department of Internal Medicine, Mount Sinai Medical Center)
Cavalcante, Ludimila (Department of Internal Medicine, Mount Sinai Medical Center) Suciu, Gabriel Pius (Department of Public Health and Biostatistics, Nova Southeastern University College of Osteopathic Medicine) Ruiz, Ana Lourdes (Department of Hematology and Oncology, Mount Sinai Medical Center) Hirzel, Alicia (Department of Pathology, Mount Sinai Medical Center) Krill-Jackson, Elisa (Department of Hematology and Oncology, Mount Sinai Medical Center) |
1 | VanderWalde A, Ye W, Frankel P, et al (2012). Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer. Biol Blood Marrow Transplant, 18, 1273-80. DOI |
2 | Schmoor C, Sauerbrei W, Bastert G, Bojar H, Schumacher M (2001). Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF. Eur J Cancer, 37, 1123-31. DOI ScienceOn |
3 | Suciu, GP, Lemeshow S, Moeschberger M (2004). Statistical Test of Equality of Survival Curves: Reconsidering the Options, Handbook of Statistics, Vol.23, Chapter 13. Eds. |
4 | Turra CM, Elo IT (2008). The Impact of Salmon Bias on the Hispanic Mortality Advantage: New Evidence from Social Security Data. Popul Res Policy Rev, 27, 515-30. DOI |
5 | Vinh-Hung V, Verschraegen C, Promish DI, et al (2004) Ratios of involved nodes in early breast cancer. Breast Cancer Res, 6, 680-8. DOI |
6 | Voduc KD, Cheang MC, Tyldesley S, et al (2010). Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 28, 1684. DOI ScienceOn |
7 | Parker JS, Mullins M, Cheang MC, et al (2009). Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol, 27, 1160. DOI ScienceOn |
8 | Nabholtz JM, Mackey JR, Smylie M, et al (2001). Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-linechemotherapy for metastatic breast cancer. J Clin Oncol, 19, 314-21 |
9 | Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L (2003). Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst, 95, 478. DOI |
10 |
Prajoko YW(1), Aryandono T (2014). Expression of nuclear factor kappa B (NF- |
11 | Ragaz J, Jackson SM, Le N, et al (1997). Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med, 337, 956-62. DOI ScienceOn |
12 | Rezaianzadeh A, Talei A, Rajaeefard A et al (2012). Vascular invasion as an independent prognostic factor in lymph node negative invasive breast cancer. Asian Pac J Cancer Prev, 13, 5767-72 과학기술학회마을 DOI |
13 | Ries LAG, Eisner MP and Kosary CL. (2001). SEER Cancer Statistics Review, 1973-1998, National Cancer Institute. |
14 | Robertson FM, Bondy M, Yang W, et al (2010). Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin, 60, 351-75 DOI |
15 | Han SJ, Guo QQ, Wang T, et al (2013). Prognostic significance of interactions between ER alpha and ER beta and lymph node status in breast cancer cases. Asian Pac J Cancer Prev, 14, 6081-4. 과학기술학회마을 DOI |
16 | Howlader N, Noone AM, Krapcho M, et al (2012).SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, SEER data submission, posted to the SEER web site, 2012. |
17 | Livaudais JC, Hershman DL, Habel L, et al (2012). Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat, 131, 607-17. DOI |
18 | Hu Z, Fan C, Oh DS, et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics, 7, 96. DOI |
19 |
Koca E, Kuzan TY, Dizdar O, et al (2013). Outcomes of locally advanced breast cancer patients with |
20 | Lee JS, Kim SI, Choi SY, et al (2011). Factors influencing the outcome of breast cancer patients with 10 or more metastasized axillary lymph nodes. Int J Clin Oncol, 16, 473-81. DOI |
21 | Livi L, Meattini I, Saieva C, et al (2012). Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. Cancer, 118, 3236-43. DOI |
22 | Mieog JS, van der Hage JA, van de Velde CJ. (2007). Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev. |
23 | Carey LA, Perou CM, Livasy CA, et al (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 295, 2492. DOI ScienceOn |
24 | Blue L, Fenelon A. (2011). Explaining low mortality among US immigrants relative to native-born Americans: the role of smoking. Int J Epidemiol, 40, 786-93. DOI |
25 | Buzdar A, Jonat W, Howell A, et al (1996). Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol, 14, 2000-11. |
26 | Edge S, Byrd D, Compton C, et al (2010). American Joint Committee on Cancer. AJCC Cancer Staging Manual, 7th ed. |
27 | Colleoni M, Rotmensz N, Peruzzotti G, et al (2005). Size of breast cancer metastases in axillary lymph nodes: clinical relevance ofminimal lymph node involvement. J Clin Oncol, 23, 1379-89 DOI |
28 | Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA Jr (2010) Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with longterm follow-up. J Am Coll Surg, 210, 797-805. DOI |
29 | Duman BB, Afsar CU, GUnaldi M, et al (2012). Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients. Asian Pac J Cancer Prev, 13, 4119-23. 과학기술학회마을 DOI |
30 | Fan C, Oh DS, Wessels L, et al (2006). Concordance among gene-expression-based predictors for breast cancer. N Engl J Med, 355, 560. DOI ScienceOn |
31 | Giordano SH (2003). Update on locally advanced breast cancer. Oncologist, 8, 521-30. DOI |
32 | Anders CK, Hsu DS, Broadwater G, et al (2008). Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol, 26, 3324-30. DOI ScienceOn |
33 | Akhsan A, Aryandono T (2010). Prognostic factors of locally advanced breast cancer patients receiving neoadjuvant and adjuvant chemotherapy. Asian Pac J Cancer Prev. 11, 759-61. |
34 | Ambrosini G, Balli M, Garusi G, et al (1988). Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin. J Clin Oncol, 6, 976-82. |
35 |
Basaran G, Devrim C, Caglar HB, et al (2011). Clinical outcome of breast cancer patients with N3a ( |
36 | Anaya-Ruiz M, Vallejo-Ruiz V, Flores-Mendoza L, Perez-Santos M (2014). Female breast cancer incidence and mortality in Mexico, 2000-2010. Asian Pac J Cancer Prev, 15, 1477-9. 과학기술학회마을 DOI |
37 | Balakrishnan N, Rao CR (2002). Race, socioeconomic status, and breast cancer treatment and survival. Elsevier Science B.V. |
38 | Banegas MP, Li CI (2012). Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women. Breast Cancer Res Treat, 134, 1297-304. DOI |
39 | Zeichner SB, Zeichner SB, Ruiz AL, Markward NJ, Rodriguez E (2014). Improved long-term survival with contralateral prophylactic mastectomy among young women. Asian Pac J Cancer Prev, 15, 1155-62. 과학기술학회마을 DOI |
40 | Woodward WA, Strom EA, Tucker SL, et al (2003) Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol, 21, 3244-8 DOI ScienceOn |
41 | Woodward WA, Huang EH, McNeese MD, et al (2006).African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer, 107, 2662-8. DOI |
42 | Woodward WA, Vinh-Hung V, Ueno NT, et al (2006) Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol, 24, 2910-6. DOI ScienceOn |
43 | Buzdar AU, Kau SW, Hortobagyi GN, et al (1992). Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy. Cancer, 69, 448-52. DOI |
44 | Montero AJ, Rouzier R, Lluch A, et al (2005). The natural history of breast carcinoma in patients with > or=10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study. Cancer, 104, 229-35. DOI ScienceOn |
45 | Keramatinia A, Mousavi-Jarrahi SH, Hiteh M, Mosavi-Jarrahi A (2014). Trends in incidence of breast cancer among women under 40 in Asia. Asian Pac J Cancer Prev, 15, 1387-90. 과학기술학회마을 DOI ScienceOn |
![]() |